123 related articles for article (PubMed ID: 1294245)
1. Differences in cerebrospinal fluid gangliosides between "probable Alzheimer's disease" and normal aging.
Blennow K; Davidsson P; Wallin A; Fredman P; Gottfries CG; Månsson JE; Svennerholm L
Aging (Milano); 1992 Dec; 4(4):301-6. PubMed ID: 1294245
[TBL] [Abstract][Full Text] [Related]
2. Human brain gangliosides in development, aging and disease.
Kracun I; Rosner H; Drnovsek V; Heffer-Lauc M; Cosović C; Lauc G
Int J Dev Biol; 1991 Sep; 35(3):289-95. PubMed ID: 1814411
[TBL] [Abstract][Full Text] [Related]
3. Gangliosides in cerebrospinal fluid in 'probable Alzheimer's disease'.
Blennow K; Davidsson P; Wallin A; Fredman P; Gottfries CG; Karlsson I; Månsson JE; Svennerholm L
Arch Neurol; 1991 Oct; 48(10):1032-5. PubMed ID: 1929894
[TBL] [Abstract][Full Text] [Related]
4. Regional distribution of brain gangliosides in Alzheimer's disease.
Kalanj S; Kracun I; Rosner H; Cosović C
Neurol Croat; 1991; 40(4):269-81. PubMed ID: 1751644
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic correlations of soluble amyloid beta-protein precursor in cerebrospinal fluid in patients with Alzheimer disease and controls.
Peskind ER; Leverenz J; Farlow MR; Ito RK; Provow SA; Siegel RS; Cleveland M; Morgan CH; Pandian MR; Corbin S; Nochlin D; Schellenberg GD; Raskind MA; Wagner SL
Alzheimer Dis Assoc Disord; 1997 Dec; 11(4):201-6. PubMed ID: 9437437
[TBL] [Abstract][Full Text] [Related]
6. Increased levels of neuronal thread protein in cerebrospinal fluid of patients with Alzheimer's disease.
de la Monte SM; Volicer L; Hauser SL; Wands JR
Ann Neurol; 1992 Dec; 32(6):733-42. PubMed ID: 1471863
[TBL] [Abstract][Full Text] [Related]
7. Age-related changes in GM1, GD1a, GT1b components of gangliosides in Wistar albino rats.
Aydin M; Cengiz S; Agaçhan B; Yilmaz H; Isbir T
Cell Biochem Funct; 2000 Mar; 18(1):41-5. PubMed ID: 10686582
[TBL] [Abstract][Full Text] [Related]
8. Differential acetylcholine and choline concentrations in the cerebrospinal fluid of patients with Alzheimer's disease and vascular dementia.
Jia JP; Jia JM; Zhou WD; Xu M; Chu CB; Yan X; Sun YX
Chin Med J (Engl); 2004 Aug; 117(8):1161-4. PubMed ID: 15361288
[TBL] [Abstract][Full Text] [Related]
9. Increased cerebrospinal fluid ganglioside GM1 concentrations indicating neuronal involvement in all stages of HIV-1 infection.
Gisslén M; Hagberg L; Norkrans G; Lekman A; Fredman P
J Neurovirol; 1997 Apr; 3(2):148-52. PubMed ID: 9111177
[TBL] [Abstract][Full Text] [Related]
10. Tau protein in cerebrospinal fluid as an aid in the diagnosis of Alzheimer's disease.
Munroe WA; Southwick PC; Chang L; Scharre DW; Echols CL; Fu PC; Whaley JM; Wolfert RL
Ann Clin Lab Sci; 1995; 25(3):207-17. PubMed ID: 7605102
[TBL] [Abstract][Full Text] [Related]
11. Gangliosides in children with autism.
Lekman A; Skjeldal O; Sponheim E; Svennerholm L
Acta Paediatr; 1995 Jul; 84(7):787-90. PubMed ID: 7549298
[TBL] [Abstract][Full Text] [Related]
12. BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls.
Laske C; Stransky E; Leyhe T; Eschweiler GW; Maetzler W; Wittorf A; Soekadar S; Richartz E; Koehler N; Bartels M; Buchkremer G; Schott K
J Psychiatr Res; 2007 Aug; 41(5):387-94. PubMed ID: 16554070
[TBL] [Abstract][Full Text] [Related]
13. Determination of gangliosides and sulfatide in human cerebrospinal fluid with a microimmunoaffinity technique.
Davidsson P; Fredman P; Månsson JE; Svennerholm L
Clin Chim Acta; 1991 Mar; 197(2):105-15. PubMed ID: 2049855
[TBL] [Abstract][Full Text] [Related]
14. Reduced CSF PLTP activity in Alzheimer's disease and other neurologic diseases; PLTP induces ApoE secretion in primary human astrocytes in vitro.
Vuletic S; Peskind ER; Marcovina SM; Quinn JF; Cheung MC; Kennedy H; Kaye JA; Jin LW; Albers JJ
J Neurosci Res; 2005 May; 80(3):406-13. PubMed ID: 15795933
[TBL] [Abstract][Full Text] [Related]
15. Altered kallikrein 7 and 10 concentrations in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia.
Diamandis EP; Scorilas A; Kishi T; Blennow K; Luo LY; Soosaipillai A; Rademaker AW; Sjogren M
Clin Biochem; 2004 Mar; 37(3):230-7. PubMed ID: 14972646
[TBL] [Abstract][Full Text] [Related]
16. Gangliosides in cerebrospinal fluid in children with autism spectrum disorders.
Nordin V; Lekman A; Johansson M; Fredman P; Gillberg C
Dev Med Child Neurol; 1998 Sep; 40(9):587-94. PubMed ID: 9766735
[TBL] [Abstract][Full Text] [Related]
17. [Volumetric brain changes and quantitative EEG in normal aging and Alzheimer's dementia].
Förstl H; Besthorn C; Sattel H; Zerfass R; Geiger-Kabisch C; Schreiter-Gasser U; Hentschel F
Nervenarzt; 1996 Jan; 67(1):53-61. PubMed ID: 8676989
[TBL] [Abstract][Full Text] [Related]
18. Normal developmental profiles of CSF gangliotetraose-series gangliosides from neonatal period to adolescence.
Izumi T; Ogawa T; Koizumi H; Fukuyama Y
Pediatr Neurol; 1993; 9(4):297-300. PubMed ID: 8216543
[TBL] [Abstract][Full Text] [Related]
19. Genotype-related changes of ganglioside composition in brain regions of transgenic mouse models of Alzheimer's disease.
Barrier L; Ingrand S; Damjanac M; Rioux Bilan A; Hugon J; Page G
Neurobiol Aging; 2007 Dec; 28(12):1863-72. PubMed ID: 17007963
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid cholinesterases in aging and in dementia of the Alzheimer type.
Atack JR; May C; Kaye JA; Kay AD; Rapoport SI
Ann Neurol; 1988 Feb; 23(2):161-7. PubMed ID: 3377438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
